Brief: Pliant Therapeutics Q2 Net Income USD -55.854 Million Vs. IBES Estimate USD -50.9 Million
Aug 07 (Reuters) - Pliant Therapeutics Q2 operating income USD -60.639 million vs. IBES estimate USD -53.8 million. * Q2 operating expenses USD -60.639 million
Recent news on Pliant Therapeutics
See all newsBrief: Pliant Therapeutics Announces Presentations At The 2026 Annual Meeting
Brief: Pliant Therapeutics Appoints David Raben, M.D., As Chief Medical Officer
RCS - Redx Pharma Limited - Redx Announces Final Audited Results
RCS - Redx Pharma Limited - Close of Series A; Strengthened Board Composition
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals